Matthew Franklin - 12 Oct 2023 Form 4 Insider Report for Akili, Inc.

Reporting relationship: President & CEO, Director
Issuer ticker: N/A
Reported as of: 12 Oct 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Oct 2023, 16:30:05 UTC
Prior SEC filing: 14 Sep 2023
Next SEC filing: 12 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Jacqueline Studer, attorney-in-fact

Key filing fact

Matthew Franklin filed Form 4 for Akili, Inc. on 13 Oct 2023.

Key facts

This page summarizes Matthew Franklin's Form 4 filing for Akili, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Oct 2023, 16:30.

Change

Previous filing in this sequence was filed on 14 Sep 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AKLI transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +1,057,180
Change %
Price: $0.000000
Shares after: 1,057,180
Date: 12 Oct 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,057,180
Exercise price: $0.4800
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option shall vest in eight equal semiannual installments over a four-year period following the grant date, subject to the reporting person's continued service on each such vesting date.